Ads
related to: huntington's disease it15 treatment protocol side effects chart uptodate- HCP Resources
Download HD Chorea Resources
for You & Your Patients.
- Cost & Coverage Support
Learn About Cost & Coverage Support
for Your Patients with HD Chorea.
- Polypharmacy
See Polypharmacy Info
for This HD Chorea Treatment.
- HD Clinical Trial Results
Review Pivotal Study Results
for Huntington's Disease Chorea.
- HCP Resources
Search results
Results from the WOW.Com Content Network
Huntingtin (Htt) is the protein coded for in humans by the HTT gene, also known as the IT15 ("interesting transcript 15") gene. [5] Mutated HTT is the cause of Huntington's disease (HD), and has been investigated for this role and also for its involvement in long-term memory storage. [6]
Tetrabenazine is used as a treatment, but not as a cure, for hyperkinetic disorders such as: [6] [7] Huntington's disease – specifically, the chorea associated with it; Tourette syndrome and other tic disorders; Tardive dyskinesia, [8] a serious and sometimes irreversible side effect of long-term use of many antipsychotics, mainly typical ...
Huntington's disease has autosomal dominant inheritance, meaning that an affected individual typically inherits one copy of the gene with an expanded trinucleotide repeat (the mutant allele) from an affected parent. [26] Since the penetrance of the mutation is very high, those who have a mutated copy of the gene will have the disease.
AB-1001 is an experimental gene therapy developed for Huntington's disease. It is intended to increase the production of the CYP46A1 enzyme and cholesterol levels in the brain. [ 1 ] [ 2 ]
The UpToDate system is an evidence-based clinical resource. It includes a collection of medical and patient information, access to Lexicomp drug monographs and drug-to-drug interactions, and a number of medical calculators. UpToDate is written by over 7,100 physician authors, editors, and peer reviewers. It is available both via the Internet ...
These often are translated into polyglutamine-containing proteins that form inclusions and are toxic to neuronal cells. Examples of the disorders caused by this mechanism include Huntington's disease and Huntington disease-like 2, spinal-bulbar muscular atrophy, dentatorubral-pallidoluysian atrophy, and spinocerebellar ataxia 1–3, 6–8, and 17.
Branaplam (development codes LMI070 and NVS-SM1) is a pyridazine derivative that is being studied as an experimental drug.It was originally developed by Novartis to treat spinal muscular atrophy (SMA); since 2020 it was being developed to treat Huntington's disease but the trial ended in 2023 due to toxicity concerns.
The Journal of Huntington ' s Disease is a quarterly peer-reviewed scientific journal in neuroscience that covers all aspects of Huntington's disease and related disorders. It was established in 2012 and is published by IOS Press. The editors-in-chief are Blair Leavitt (University of British Columbia) and Leslie Thompson .
Ads
related to: huntington's disease it15 treatment protocol side effects chart uptodate